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Abstract
Background: Within its reform efforts, the Government of Tajikistan is embracing the essential role of primary
health care (PHC) in decreasing out of pocket (OOP) expenditures and increasing equity in access to health services.
In the light of the increasing burden of disease relating to chronic conditions, we investigated OOP expenditures of
patients with chronic conditions within a PHC setting; and if and how those expenditures are impacted by several
interventions currently being implemented within Tajikistan.
Methods: A cross-sectional survey among 1600 adult patients who had visited a PHC facility was conducted. The
data obtained through interviews were descriptively analysed, and logistic regressions and gamma generalized
linear models were performed.
Results: The total OOP expenditures related to a patient’s last visit to the PHC facility were 17.2 USD for those with
chronic conditions and 13.9 USD for those visiting due to an acute condition. Adjustment for potential confounders
reduced the discrepancy from 3.3 USD to 0.5 USD. This convergence of costs was only observed in districts covered
by the Basic Benefit Package (BBP), a governmental pilot project, aiming to standardise exemptions for payment
and formal co-payments for health care services. Hence, we found the BBP to have a protective impact for patients
with chronic conditions. However, considering the demographics of these patients (older in age, with greater
dependency on pensions and social aid, and lower socio-economic status) in combination with the 40% higher
utilisation rate of PHC and the high rate of onward referrals to specialists; it is clear that patients with chronic
conditions continue to face substantial long-term costs and disadvantages.
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Conclusions: After accounting for confounders, patients with chronic and acute conditions faced similar costs
related to a single visit to a PHC facility in districts covered by the BBP. However, greater efforts are required to
ensure that citizens are well informed about their rights to health care, the BBP and the services that should be
provided at no cost at the point of delivery. Moreover, the needs of patients with chronic conditions warrant a
more integrative approach that takes long-term expenditures and services beyond the level of PHC into account.
Keywords: Out of pocket expenditure (OOP), Primary health care (PHC), Family medicine, Chronic conditions,
Chronic disease, Non-communicable disease (NCD), Tajikistan, Central Asia
Background
In its 2014 Global Status Report on Non-communicable
Diseases (NCD) the WHO identified NCDs as one of the
major health challenges of the twenty-first century [1].
As the leading cause of death globally, NCDs were re-
sponsible for 68% of the world’s 56 million deaths in
2012. More than 40% of them were premature deaths
under age 70 years and almost three quarters of all NCD
deaths occur in low- and middle-income countries [1].
In line with these findings, Tajikistan is also experien-
cing a shift in disease patterns. While infectious diseases
are still common, the prevalence of chronic conditions
has been rising steadily since the mid-1990s [2]. In 2016,
69% of all deaths were estimated to be caused by chronic
conditions, in particular cardiovascular disease (CVD)
(42%), followed by cancer (10%), respiratory diseases
(4%), diabetes (2%) and other NCDs (12%) [3].
One of the objectives of the Global NCD Action Plan,
highlights the need to address prevention and control
for NCDs through primary health care (PHC) and uni-
versal health coverage [4]. Accessibility and affordability
of health care are greatly dependent upon country level
choices regarding the financing modalities. While many
high-income countries have a mixture of private and
public funding, low- and lower-middle income countries
such as Tajikistan still rely heavily on direct financing by
households such as out of pocket (OOP) payments by
patients to the health care provider [5]. In 2014, 61.7%
of the total health expenditure (THE) was found to be
comprised of OOP payments [2]. Given that the monthly
average wage was estimated to be 115.7 USD in 2016, it
is apparent that OOP payments can severely hinder
access to health care especially for those of poor socio-
economic status (SES) [6]. Patients with chronic condi-
tions can be especially exposed and vulnerable to such
costs, as they typically need prolonged care and rely on
multiple and regular use of services.
NCD multi-morbidity has been associated with in-
creased OOP expenditures in middle income countries,
mainly due to higher expenditures on medicine which
can lead to non-adherence to treatment [7, 8]. Even in
contexts with social protection schemes in place,
household SES influences access to care among patients
with chronic conditions, whereby poorer population seg-
ments typically face major barriers in obtaining essential
services and financial hardship [9]. A study in India in
2012 has provided evidence that OOP payments for
chronic conditions are a major driver of impoverishment
[10]. While the wider association of poverty and chronic
conditions has been well demonstrated, including how
the compromised well-being of a chronically ill person
might not allow them hold a regular job thus further de-
priving them of income while they often face higher
costs for health care over an extended period of time
[11, 12]. Moreover, there is evidence that the poorer seg-
ments of society have a generally higher exposure to po-
tential risk factors for chronic conditions [1].
The Government of Tajikistan recognizes the import-
ance of improving access to care and reducing inequities
through a more decentralised model of PHC compared
to the centralised system focusing on secondary and ter-
tiary hospital care inherited from the Soviet period.
One of the reforms the government initiated was the
introduction over the last decade of the basic benefit
package (BBP [2]). This package entitles the entire popu-
lation to free (at point of care) essential PHC and emer-
gency services (e.g. diagnostic consultations, ambulance
service) and free secondary and tertiary services for pre-
defined “vulnerable” groups based either on social status
(e.g. children under one, veterans) or health indication
(e.g. patients with tuberculosis). The rest of the popula-
tion pays formal co-payments (e.g. curative manipula-
tions/services, such as physiotherapy, stitching of
wounds etc. are only free for “vulnerable” patients) [2].
The BBP is in the pilot phase and currently being imple-
mented in around a quarter of the districts of the coun-
try. However, due to regulatory constraints, the
implementation of the BBP package is not without its
challenges – most notably the guidelines for exemptions
can be confusing for both patient and health care pro-
vider resulting in inconsistent application [13].
Since 2003, the “Enhancing Primary Health Care Ser-
vices” (EPHC) project (previously Project Sino) has been
running in Tajikistan, supporting the Government in
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their efforts to strengthen PHC services by providing
training for medical professionals, supporting infrastruc-
tures for PHC clinics and strengthening community par-
ticipation and empowerment.
In the framework of the EPHC project, progress in
strengthening PHC services and monitoring of the devel-
opment of health expenditures have been tracked
through a series of household surveys since 2005 [14].
Focusing on only the oldest and the most recent surveys
(2005, 2011 and 2014); they have indicated a compara-
tively high level of satisfaction with the received health
care [14–16]. In 2014, informal payments have been re-
ported by 34% of the patients [17]. It has been shown
that expenditure for medication is the biggest financial
burden for patients. SES-related inequalities have been
observed across both households and districts. However,
until now there has been no assessment of the differ-
ences amongst illness or reasons for consultation.
In the light of the epidemiological transition and the
considerable efforts to reform the health system, it is
warranted to examine the economic burden of patients
with chronic conditions more closely. We anticipated
that the utilisation rate of PHC services is increased for
patient with chronic conditions, however the intranspar-
ent and erratic costing of PHC services make it difficult
to hypothesise the effect of the health care reforms on
patients with chronic conditions. Further evidence was
therefore needed to examine how the strengthening of
PHC might have affected the economic burden of pa-
tients with chronic conditions.
Consequently, this new iteration of the household
study aimed to assess the development of the OOP ex-
penditures and to uncover the situation of patients with
chronic conditions, compared with patients visiting the
PHC facility for acute conditions.
Methods
Study design
To respond to the study objective, we conducted a
cross-sectional study among patients that visited PHC
facilities between February and May 2016. Following a
visit to a PHC centre in the previous 3 months, patients
were interviewed at home using a structured question-
naire to find out about their last visit to the health
centre, the related expenditure, as well as medicine pre-
scription and usage.
Study population and sampling methods
The study covered eight districts of rural or semi-rural
Tajikistan. In the Khatlon region, Dangara, Hamadoni
and Vose districts, as well as Varzob, Faizabad, Rudaki,
Shakrinav, Tursunzade as part of the Region of Repub-
lican Subordination (RRS). Six of the eight study districts
are included in the BBP pilot project, except Rudaki and
Vose. The study population were adult users of PHC
services (health centres or rural health centres). A multi-
level sampling strategy was applied to select the facilities
and the number of respondents in each location. The
number of PHC facilities to be included in the study for
each district was chosen proportionally to the total num-
ber of PHC facilities in the respective district. Addition-
ally the PCH facilities were selected to represent both
accessible and remote facilities. All facilities were staffed
with at least one family doctor (FD). In a second step,
the total number of respondents per PHC facility was
chosen proportionally to the total number of patients’
visits in the previous year to this facility. The respon-
dents were then selected using a systematic random
sampling technique from the registries at the health
centre.
The sample size of 1600 patients and the sampling
methodology was aligned to the previous studies con-
ducted in 2011 and 2014 to enable meaningful compari-
son and establishment of a time-trend [15, 16]. The
sample size was based on the requirement to detect at
least 10% difference in total OOP expenditure and a 7%
difference in the access to medicine across SES status
using a power of 90% and a significance level of 5% with
possible stratification along the eight districts.
Data collection and analysis
Selected patients were visited at home and interviewed
after obtaining oral consent. The interviewers were lo-
cals with previous experience in conducting surveys and
received additional training for this study. The data were
collected using a questionnaire adapted from the previ-
ous studies with small updates to facilitate analysis on
patients with chronic conditions (see Additional file 1
for the complete questionnaire) [16]. In addition to
demographic variables, the questionnaire aimed to assess
the OOP expenditure, experiences with the FD and pre-
scribed and bought medicine. The inquiry about OOP
expenditure was divided into six categories: i) formal
fees for consultation; ii) informal payments to the FD or
family nurse; iii) the value of non-monetary gifts given;
iv) the amount of money spent to reach the health
centre; v) the amount of money spent for travel to ob-
tain medicine; vi) the expenditures for the prescribed
medicine. Furthermore, the participants’ SES was esti-
mated based on the assessment of variables including in-
come source, housing infrastructure, meat consumption
and similar factors using principal component analysis
to compute a household asset index.
Data were collected in May 2016 with tablets and the
software package CSPro. Independent monitoring activ-
ities were pursued to ensure data quality and adherence
to the described methodology.
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The data were analysed using Stata/IC 14.0 software.
For univariate analysis, associations were tested for stat-
istical significance using the chi-squared test for binary
and categorical variables. This test was also used to as-
sess linear associations (dose-response relationships).
For continuous variables, the Wilcoxon rank-sum test as
well as the Kruskal-Wallis test were used for testing be-
tween two or more groups respectively. For binary vari-
ables logistic regressions were run and ordinal logistic
regressions for ordinal variables. To assess the different
amounts of expenditure (per category and overall) and
their determinants, generalized linear models (GLM) for
Gamma-distributed variables were used. The Gamma-
distribution can be used to model monetary variables
with their typical right-skewed distribution, and GLM-
models for Gamma-distributed variables have been
shown to be useful for the prediction of average costs
and have been applied before in health care settings [18,
19]. Regression models were run according to a stepwise
approach. In a first step, an empty model was run only
including consultation reason as explanatory variable. In
a second step, the model was adjusted for sex and age.
Finally, a full model was developed with included reason
for consultation (acute, chronic), age categories, sex,
coverage status by BBP, region (Khatlon, RRS), SES sta-
tus and number of doctors’ visits in the last 12 months.
After identifying the strong confounding effects of the
BBP project on our outcome variable, we have decided
to further stratify the full model (excluding coverage sta-
tus by BBP) by BBP status. Stratified findings are only
reported where significant differences were observed to
improve the readability of the findings.
The OOP spending was always assessed two-fold: (i)
The percentage of patients reporting to have spent
money (ii) The mean of expenditure of all patients
who have spent money. The amount of money is pre-
sented in USD, the currency exchange rate of 7.87
Tajik somoni (TJS) per one US dollar (USD) as of
May 2016 was used.
In the questionnaire patients were divided by their
reason for consultation, differentiating between “acute
disease”, “chronic disease”, “pregnancy”, “injury or poi-
soning” with the option of “other”. For the analysis pa-
tients not visiting for either acute or chronic conditions
were omitted as they were difficult to compare: many of
them were pregnant women who represent a different
subpopulation, while the population visiting for injury
and poisoning was rather small.
To complement the information collected through the
household survey, 18 in-depth interviews were con-
ducted. The interviews were transcribed and translated
into English and thematically coded and analysed using
the software package MAXQDA 12. The information
from these interviews is drawn on where it is helpful for
interpreting the collected data and results, but is not
otherwise discussed in detail.
Results
Characteristics of the total sample population
Among all patients contacted, 487 (30% of the antici-
pated sample size) did not agree to be interviewed at
home and were replaced by other study participants.
Through the weighted sampling method the following
numbers of patients were interviewed in the districts
Dangara 12% (N = 191); Varzob 10% (N = 166); Tursun-
zade 27% (N = 439); Shahrinav 5% (N = 79); Vose 16%
(N = 250); Hamadoni 11% (N = 183); Rudaki 15% (N =
235) and Faizabad 4% (N = 57).
The majority of the interviewed patients were female
(85%). This gender difference persisted even when ac-
counting for pregnancy-related visits (76 to 24%). The
median age was 31 years old with an average of 11 years
of education. The main reason for consultation was
pregnancy with 38% (N = 609), followed by chronic con-
ditions with 34% (N = 542) and acute diseases (23%, N =
363) (Table 1). Another reason for consulting the FD
was the need for a medical certificate, e.g. for meeting
the legal requirements for a wedding.
Patients with chronic conditions were found to have a
higher age (median 50 years old compared to 35 years),
higher dependency on pensions and social aid (21%
compared to 13%) and of lower SES (Table 2). There
was no difference in the distribution of patients with
chronic conditions by status of BBP coverage. Differ-
ences were found in terms of geography: of all patients
living in the Khatlon region, 70% reported having a
chronic condition, while in the RRS the prevalence was
only 51%.
Patients with chronic conditions consulted the FD
more often than the other patient groups with a median
of 5 visits in the last 12 months compared to 3, for pa-
tients with acute conditions. Furthermore, 60% of the
patients with chronic conditions stated that their last
visit was a follow-up visit to previous consultations. It
should be noted that only the costs related to the most
recent consultation were explored.
Table 1 Reason for consultation at the last PHC centre visit,
Tajikistan, 2016
Reason for consultation N
Acute conditions 361 (23%)
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After adjustment for other explanatory factors, only
age and region were shown to be significant predictors
for chronic conditions, as shown in Fig. 1.
Overall respondents with chronic conditions rated
their own health as worse than patients with acute con-
ditions, with 28% rating their health as poor or very poor
compared to 13% of patients with acute conditions.
Access to PHC services and perceived quality of care
Of the 900 patients visiting the FD for either chronic or
acute conditions, 74% perceived the distance to the PHC
facility as acceptable and easy to access. The satisfaction
with the distance did not correlate with the time needed
to reach the PHC facility. Of the 90 patients, which re-
ported that the PHC facility was too far and difficult to
access 72% were suffering from chronic conditions.
However, age was found to be a confounder of this asso-
ciation, as mostly patients older than 56 years expressed
difficulties accessing the PHC facility (56–70 years old:
aOR 0.4, p < 0.01; 71+ years old: aOR 0.3, p = 0.02).
Patients with chronic conditions were more frequently
referred to a specialist (49%) than those suffering from
an acute problem (41%). Even after accounting for other
factors, being chronically ill or aged between 21 and 55
years increased the odds of being referred. However, the
largest predictor was living in RRS region where the ad-
justed odds ratio (aOR) to referral was 3.5.
The overall satisfaction with the care received was re-
ported to be high. The majority of patients with chronic
disease were either very satisfied (41%) or satisfied
(56%), similar to the patients with acute conditions (47
and 50%).
Out of pocket expenditures
Percentage of paying patients
Patients with chronic conditions more often reported no
expenditures at all (16%) compared to patients with
acute conditions (10%). This difference could also be
seen in all regression models (unadjusted, partially ad-
justed and full model, see Table 3). However, stratifica-
tion for BBP coverage showed that the beneficial effect
for patients with chronic conditions only held true in
districts covered by the BBP (aOR 0.5, p < 0.01).
Among all patients with either chronic or acute
conditions, 18% reported paying formal fees for con-
sultation. Thirteen percent of patients with chronic
conditions and 12% of patients with acute conditions
reported informal payment. Only a small number of
patients reported giving non-monetary gifts (1%).
Seventy-one percent and 73% of chronic and acute
conditions respectively had to procure medicine in re-
lation to their last consultation at the PHC facility.
Forty-five percent of each patient group reported add-
itional expenditure for travel to obtain the medicine.
Travel expenses varied slightly across conditions; 24%
of patients with chronic conditions reported incurring
expenses for travel to the PHC facility, while 32% of
patients with acute conditions reported such expenses.
In the model including other explanatory variables,
regional differences accounted for some of this dis-
crepancy - as patients from the RRS region had
higher odds of paying for transport to the PHC facil-
ity (Table 3). No differences between the patient
groups were observed for incurring other types of
expenditures.
Table 2 Demographics of patients consulting the doctor for acute and chronic conditions, Tajikistan, 2016
Variables Acute Chronic Total
Number of respondents 361 (40%) 539 (60%) 900 (100%)
Gender Female 270 (75%) 414 (77%) 684 (76%)
Male 91 (25%) 125 (23%) 216 (24%)
Median age 35 50 45
Median number of years of education 9–11 9–11 9–11
BBP not covered 99 (27%) 171 (32%) 270 (30%)
covered 262 (73%) 368 (68%) 630 (70%)
Region Khatlon 125 (35%) 291 (54%) 416 (46%)
RRS 236 (65%) 248 (46%) 484 (54%)
SES 0–20% Poorest 81 (22%) 147 (27%) 228 (25%)
20–40% Poor 71 (20%) 133 (25%) 204 (23%)
40–60% Middle 69 (19%) 102 (19%) 171 (19%)
60–80% Wealthy 68 (19%) 91 (17%) 159 (18%)
80–100% Most wealthy 72 (20%) 64 (12%) 136 (15%)
Median number of visits to a FD in the past 12 months 3 5 4
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Amount of money spent
Patients with chronic conditions reported an overall
OOP expenditure of 17.2 USD related to their visit to
the FD. OOP expenditures of patients with acute condi-
tions were lower at 13.9 USD. However, this observed
difference was not statistically significant and taking
other explanatory variables into account diminished it
further, resulting in 16 USD total OOP expenditures for
chronic conditions and 15.5 USD for acute conditions
respectively (see Table 4). Stratification by BBP coverage,
showed that patients with chronic conditions pay signifi-
cantly more than patient with acute conditions in dis-
tricts not covered by the BBP (27.3 USD and 17.7 USD,
p = 0.04) even after adjustment for the other variables.
Patients with chronic and acute conditions reported
similar amounts of informal OOP expenditure for
Table 3 Odds ratio of frequency of paying (0 = no money paid, 1 =money paid), for patients with chronic condition as consultation
reason and its associated p-value from different gamma GLM models, Tajikistan, 2016
Unadjusted Adjusted for age and sex Full model
OR p-value aOR p-value aOR p-value
Formal 1 0.84 1.2 0.31 1.3 0.26
Informal 1.1 0.52 1.3 0.33 1.4 0.14
Medicine 0.9 0.69 0.9 0.40 0.8 0.17
Travel to a FD 0.7 0.02 0.7 < 0.01 0.7 0.07
Travel to obtain medicine 1 0.88 0.9 0.41 0.9 0.43
Total OOP 0.6 0.01 0.5 < 0.01 0.6 < 0.01
Fig. 1 Logistic regression on consultation reason at the primary health care centre (0 = acute conditions, 1 = chronic condition), univariable and
multivariable model, Tajikistan, 2016
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consultation (1.2 USD and 1.1 USD), as well as similar
expenditures for the travel to obtain medicine (2.8 USD
and 2.4 USD). The value of non-monetary gifts was not
evaluated due to the negligible percentage of patients
reporting this expenditure.
Acute and chronically ill patients paid a similar
amount for consultations (4.1 USD and 3.8 USD). Even
after adjusting for all variables, only the age group of 56
to 70 years old and living in the RRS region showed in-
creased odds for higher amount of formal expenditures,
while there were no differences between patients with
acute and chronic conditions (Table 4).
Patients with chronic conditions that were not covered
by the BBP had significantly higher expenses for medi-
cine (45.4 USD) than patients with acute conditions 29.6
USD, p = 0.05), while there was no significant difference
in districts covered by the BBP. Medicine costs greatly
exceed the expenditures for all other services.
Medicine prescription and purchase
The percentage of patients leaving the FD with a pre-
scription for at least one drug was similar for those suf-
fering from a chronic condition (88%) and those with an
acute condition (85%). However, the fully adjusted re-
gression model showed decreased odds for medicine
prescription for patients with chronic conditions
(Table 5). After stratification by BBP coverage, only
chronically ill patients living in districts covered by the
BBP had significantly decreased odds for medicine pre-
scription (aOR 0.5, p = 0.02).
Overall a high prescription rate for intravenous (IV)
injections, such as “drips” (39% for acute conditions and
55% for chronic), other types of injections ([intramuscu-
lar, subcutaneous or intradermal injections or others],
51 and 54%), antibiotics (both 50%) and vitamins (both
60%) was observed. Patients with chronic conditions re-
ported a significantly higher prescription rate for IV-
injections; this difference persisted in the regression
model even when all explanatory variables were taken
into account (Table 5).
Of all the 774 patients being prescribed medicine, 9%
of those with chronic conditions and 7% of patients with
acute conditions reported not to have obtained any or
only part of the drugs. This was mainly due to a lack of
money – cited by 78% of patients with chronic condi-
tions and 63% of patients with acute conditions. In
Table 4 Amount of money paid, if payment has been reported: Coefficients of chronic condition as consultation reason and its
associated p-value from different logistic regression models, Tajikistan, 2016
Unadjusted Adjusted for age and sex Full model
Acute* Chronic* p-value Acute* Chronic* p-value Acute* Chronic* p-value
Formal 4.1 3.8 0.90 7 3.2 0.02 4.8 3.2 0.23
Informal 1 1.2 0.52 1.1 1.2 0.59 1.1 1.2 0.88
Medicine 16.1 20.8 0.07 16.6 20.5 0.16 21 23.4 0.42
Travel to a FD 0.8 0.9 0.51 0.8 0.9 0.63 0.9 0.9 0.90
Travel to obtain medicine 2.4 2.8 0.32 2.3 2.8 0.30 2.4 2.8 0.27
Total OOP 13.9 17.2 0.12 14.5 16.7 0.31 15.5 16 0.82
*Values in USD
Table 5 Odds ratios for medicine prescription and purchase for patients with chronic condition as consultation reason and its
associated p-value from different gamma GLM models, Tajikistan, 2016
Unadjusted Adjusted for age and sex Full model
OR p-value aOR p-value aOR p-value
Has medicine been prescribed? 0.7 0.12 0.68 0.07 0.61 0.03
Type of drug prescribed: IV 1.9 < 0.01 1.6 < 0.01 1.4 0.05
Non-IV 1.2 0.34 1.1 0.55 1.1 0.65
Antibiotics 1 0.91 1.1 0.65 1 0.86
Vitamins 10.2 0.88 1.1 0.63 1.1 0.71
Received ≥ 5 prescriptions 1.5 < 0.01 1.55 0.01 1.5 0.01
Has all medicine been obtained? 1.3 0.30 1.5 0.06 1.5 0.14
Non-prescription medicine 1.5 < 0.01 1.45 0.07 1.3 0.15
Supplementary treatment 1.8 < 0.01 1.6 < 0.01 1.3 0.18
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districts covered by the BBP patients with chronic condi-
tions were more likely to not obtain any or all prescribed
medicine (aOR 2.2, p = 0.03).
Patients with chronic conditions seemed to rely more
on drugs that were not prescribed by the FD (33%) and
supplementary treatment (28%) than patients with acute
conditions (25% reported using non-prescribed drugs
and 18% supplementary treatment). However, both these
effects diminished after taking other explanatory vari-
ables into account. Non-prescribed medicine usage was
highest for females and the age group between 56 and
70 years, while the use of supplementary treatment was
more widespread in older age groups and in Khatlon re-
gion. Supplementary treatment included the use of herbs
(32%), traditional treatment (28%), praying (19%), as well
as consultations with other doctors (17%).
Discussion
Access to PHC services and quality of care
The satisfaction expressed with PHC services was high.
These findings are in line with the results from the pre-
vious studies [15, 16]. It is difficult to judge whether this
is a true perception of the care received or if the high
rating could be attributed to the general unwillingness
to criticise for fear of possible consequences. Other stud-
ies have suggested a potential gratitude bias to limit the
reporting of negative opinions [20].
OOP expenditures for one visit to the FD
To effectively analyse the financial burden on house-
holds relating to a PHC consultation, the expenditures
have to be viewed in context of the financial capacities
of the Tajik population. The monthly average wage of
those in paid employment in Tajikistan in May 2016 was
estimated to be 115.7 USD [6]. However, there are
strong discrepancies between rural and urban areas, with
households in rural areas and especially those relying on
agriculture or the informal economy being typically
much poorer. As this study has been conducted in
mostly rural settings, it has to be assumed that the
household income among the study population is sub-
stantially lower than the estimated country average. Fur-
ther, since 2015 the international poverty line was set at
1.9 USD (PPP) a day, equalizing to 57.8 USD a month.
In was estimated that in 2015 31.3% of the population in
Tajikistan lived below the national poverty line [21]. In
this context, the findings of the study show that OOP
expenditures for health remain a substantial burden to
households in rural Tajikistan with one visit to the PHC
facility amounting to one seventh of the average monthly
wage or almost a quarter of the income of the patients
below the poverty line.
Consistent with the findings of the survey in 2014 fo-
cusing on medical expenditures and studies from the
neighbouring Kyrgyzstan and other lower income coun-
tries, medicine costs still account for the biggest propor-
tion of OOP expenditures relating to PHC use [16, 22,
23]. Most likely, this finding is attributable to insufficient
supplies of pharmaceuticals from the essential drug list
and poor prescription patterns, such as over-prescription
of expensive injections, prescription of antibiotics for
non-bacterial causes and over-prescription in general
[2]. The high number of prescribed antibiotics and injec-
tions follows a similar pattern to other countries in
Central Asia, China and beyond [24]. In the in-depth in-
terviews, patients reported that they seem to put more
trust in the effectiveness of injections than pills and re-
quest them from providers. This observation would be
in line with studies from other developing countries
such as Uganda, Indonesia and Pakistan, who have re-
ported that injections are perceived as faster, more effi-
cient or even safer than pills [25, 26]. It has also been
shown that the informal payments in particular seem to
be tied to small services, e.g. one injection for one TJS,
so financial interest to prescribe injections could be in
play on the provider side.
Informal payments remain a common practice in
Tajikistan with one in eight patients reporting to have
paid on an informal basis. However, it seemed difficult
for patients to talk about those spendings, but also to
differentiate them from the formal payments for consult-
ation. Therefore, the actual percentage of patients
reporting to have paid on an informal basis might be
underestimated. Based on the in-depth interviews, we
suggest that health care providers rarely request informal
payment, but patients seem to provide it on their own
accord. The voluntary nature of these informal payments
is arguably questionable. Reasons for payment could be
divided into four categories: i) payment out of gratitude
for good health to ensure emotional and spiritual well-
being; ii) attempt to ensure continuous and good quality
of care; iii) perception that the time and material used
by the provider must be paid; iv) abiding to traditions on
informal payments. Informal payments and expectations
are rarely discussed with the FD.
The fact that patients from all districts reported pay-
ment on an informal basis (even though the BBP aims to
formalise all payments) and patients from districts not
covered by the BBP reported a higher rate of formal pay-
ments, even though in these districts access to all health
services should be free [2] suggest that patients seem to
lack awareness of their right to free PHC and therefore
cannot question the appropriateness of expenditures they
face. This is supported by the in-depth interviews con-
ducted subsequently to the data collection. Consequently
and as to reduce the financial burden to households, it ap-
pears important that the population and health service
users are adequately informed on their entitlements.
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Experiences of patients with chronic conditions at PHC
level
As only a single visit to the PHC centre was assessed,
large differences in OOP expenditures for acute and
chronic patients were not expected. The greater financial
burden for patients with chronic conditions stem from i)
higher utilisation rate of PHC services; ii) the need for
diagnostics tests, medicines and treatments, beyond the
capacities of PHC in Tajikistan.
Indeed patients with chronic and acute conditions re-
ported similar OOP expenditures related to a single visit
PHC facility, if controlled for confounding. Most dis-
crepancies between patients visiting for acute and
chronic conditions diminish, when other variables such
as age or gender are taken into account. Conversely, pa-
tients with chronic conditions were more likely to not
report any expenditure at all than patients with acute
conditions.
However, further analysis showed that these effects are
strongly confounded by the BBP and only hold true in
districts covered by the BBP.
The impact of the basic benefit package
The fact that the BBP exempts certain vulnerable groups
including chronic conditions, such as diabetes mellitus,
HIV/AIDS or tuberculosis, from payment suggest a bet-
ter protection from costs in districts covered by the BBP.
Indeed, patients with chronic conditions reported paying
significantly less often and also paying a smaller amount
compared to patients with acute conditions, if covered
by the BBP package. Additionally patients pay a similar
amount for medicine regardless of consultation reason if
covered by the BBP. This suggests that the essential
drugs which can be obtained at the PHC level to treat
chronic conditions, are not disproportionately expensive
[27]. However, it should be noted that the costs of drugs,
prescribed and obtained at secondary or tertiary level,
which are likely more expensive, have not been assessed
in this study. Conversely, patients with chronic condi-
tions reported significantly higher expenditures if not
covered by the BBP. The lowering of the medicine costs
and total expenditures suggests a protective impact of
the BBP for patients with chronic conditions. However,
patients with chronic conditions in BBP covered districts
were also more likely to forego at least some of the pre-
scribed medicine than patients not covered by the BBP,
and reported a lack of money as the reason. This finding
is counterintuitive, however we see three possible expla-
nations why the BBP may not have a protective effect: i)
inconsistent implementation due to the complicated lists
of free or partially covered services; ii) the needs of
patients with chronic conditions for drugs which are
not on the essential medicine lists and less likely to
be covered by the BBP; iii) the fact that the non-
availability of drugs can happen regardless of the pay-
ment modality [13].
Medicine prescription and purchase
In terms of overall medicine purchase, a relatively high
percentage of patients with chronic conditions reported
obtaining all the drugs that were prescribed. However,
based on this information, it cannot be concluded that
procuring medicine is not problematic. Several patients
reported being unable to forego their medicine, as it was
essential to stop their health from completely deteriorat-
ing. Most of the interviewed patients gave their health
very high priority above all other necessities. Generally,
the patients were ready to take all necessary measures to
obtain the medicine: borrowing money from family
members, accumulating debts, impoverishment, skimp-
ing on other needs [28]. Lastly, the percentage of pa-
tients buying the medicine does not reflect the medicine
usage. Patients reported rationing the drugs and not
strictly adhering to the prescription recommendation.
Similar behaviours in obtaining and saving funds for
health care have been described in Mongolia [29].
Higher PHC service utilisation rate
Even if the BBP package seemed to alleviate some of the
financial burden of patients with chronic conditions, our
findings do not allow the conclusion that patients with
chronic conditions do not suffer substantial disadvan-
tages when seeking appropriate health care. This study
only reflects the costs of one visit to the doctor, while
chronic conditions often require long-term treatment.
Hence, this study can only estimate the true recurring
health care costs. Because patients with chronic condi-
tions reported visiting the doctor more often (on average
5 times in the past 12 months compared to 3), the an-
nual spending for PHC is expected to be 40% higher for
patients with chronic conditions. This assumption would
be in line with other studies: patients with NCDs are as-
sociated with an increased utilisation of health services
[7] and a study in India has shown a high correlation of
yearly OOP expenditures and chronic illnesses [30]. The
prolonged treatment and management of chronic condi-
tions further puts those patients under stress.
The lack of differences between expenditures regard-
ing a single visit to the FD can also be attributed to the
fact that PHC in Tajikistan only provides basic services
and medicine [2]. The essential list of drugs to treat
chronic diseases at PHC level has specifically been de-
signed to be affordable [27]. However, many diagnostic
tests or extended treatments have to be done upon refer-
ral and are handled by a specialist and/or at hospital
level. Patients with chronic conditions are likely to use
and benefit from the same resources as patients with
acute conditions and seek additional treatment outside
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of the PHC setting, which is also reflected in the higher
referral rate, as found in this study. The costs occurring
from these referrals (including diagnostic procedures)
could not be assessed by means of this study.
Confounding effects: the demographics of patients with
chronic conditions
Based on the overall OOP expenditure patients with
chronic conditions pay more in districts not covered by
the BBP, while the BBP seems to level the OOP expendi-
tures. However, inequity in accessing health care is not
yet achieved, as the average patient consulting the FD
for chronic conditions differs from one consulting for an
acute condition: Patients in this study with chronic dis-
ease were of higher age, more likely to be dependent on
social support or pensions, and more likely to belong to
a lower SES group. The concurrence of these character-
istic suggests that patients with chronic conditions were
more likely to lack resources to pay for their needs or
need to spend higher proportions of their monthly in-
come on health care.
This concurrence of disease status, age and SES status
is problematic, as these population groups are already
vulnerable to costs on an individual level. A study from
2013 has shown that reduction of poverty among the
elderly is more dependent on private transfers (i.e. re-
mittances, borrowed money from family) rather than
public transfers (i.e. social or old age pension), highlight-
ing the importance of a social network and potentially
insufficiency of the public protection system [31, 32].
Various studies indicate inequities of OOP expendi-
tures with substantially higher relative expenditures
among low-income households [10, 14, 33–35]. This
study supports those findings. While there was no asso-
ciation between absolute OOP expenses and SES, the
relative share of OOP expenditures is higher for low-
income or low-SES households. A study in 2010 re-
ported an association of the ability to pay with a higher
amount of OOP expenditures related to hospitalization
[36]. Another study from 2015 in Malawi showed the
highest OOP expenditures for the wealthiest, but the
poorer spend the bigger proportion of their total income
[37]. It is suggested that a similar pattern is here in place
as well: Reported OOP expenditures did not vary signifi-
cantly among SES status, but patients with chronic con-
ditions (more often of lower SES) rated their own health
worse than patients with acute conditions. It has been
established that the OOP expenses are a risk for impov-
erishment of households, which in turn hinder the ac-
cess to adequate treatment, leading to a vicious cycle of
poverty and disease [1, 38, 39]. Due to this correlation of
poverty, dependence and chronic conditions, inequality
in terms of OOP expenditures for PHC services might
not present themselves in the form of higher costs, but
rather the patient suffers from the stress and pressure to
acquire money to pay the services and the need for re-
ferral and additional treatment, to the basic services the
of the PHC provide.
Limitations
Almost one third of patients initially contacted declined
participation, which could have led to a selection bias.
The non-respondent rate is likely explained by the fol-
lowing: women were not allowed to participate without
their husband or mother-in-law present, men do not en-
gage with strangers coming to their house in fear of be-
ing drafted into the military, people were afraid of
repercussions if they do not give the “correct” reply (an-
ecdotally, we have been told of “fake surveys” being con-
ducted) and talking about money and especially the lack
thereof is a very private and sensitive topic. The strong
skew in the sampling distribution of female to male par-
ticipant towards women can mainly be attributed to the
high dependency of Tajikistan on remittances, resulting
in many men emigrating to other countries, leaving the
women behind [40, 41].
It needs also to be noted that the patients that were
interviewed were the ones, which could afford to have
made at least one visit to the health centre in the previ-
ous 3 months. In this study we only investigated the dir-
ect costs occurred when visiting a health facility, but
could not assess the indirect costs (e.g. absenteeism/
productivity losses) of the patients, nor their care givers
in the family. Those indirect costs are also likely to heav-
ily affect patients with chronic conditions.
The study is based on interviews and hence, self-
reported data. Self-reported data are always subject to
recall and reporting bias. To limit recall bias only pa-
tients that had visited a health facility in the previous 3
months were included. For a few health facilities, the
data collection team could not find enough patients
within this timeframe and extended up to 5 months,
which might have increased the recall bias.
The reported rates of referral in this study were very
high when compared to estimates of previous studies
[42]. Possibly the question was misunderstood, and per-
haps even the use of a diagnostic test was considered by
respondents as a referral to a specialist.
Conclusions
In conclusion, this study showed that after adjustments,
patients with chronic and acute conditions incur similar
costs related to a single visit to the FD at PHC level for
districts involved in the BBP pilot. The BBP and the
strengthening of PHC services seemed to have a positive
effect on the expenditures of patients with chronic con-
ditions in regards to one visit to the FD and it will be
important to ensure citizens are well informed about its
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intention and their rights. Still, patients with chronic
conditions often belong to a vulnerable subpopulation
(the poor and elderly). Moreover, most of the potential
financial hardships for patients with chronic conditions
are likely to be related to the long-term implications of
these conditions: Prolonged treatment, higher utilisation
rate of health services and need for services beyond the
current possibilities of PHC in Tajikistan. Hence, an in-
tegrative approach that accounts for long-term expendi-
tures and services beyond the level of PHC is needed to
protect patients with chronic conditions.
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